Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Reneo Pharmaceuticals, Inc. (RPHM)  
$1.65 0.00 (0.00%) as of 4:30 Tue 3/26


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 33,810,000
Market Cap: 55.79(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.34 - $10.5
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Reneo Pharmaceuticals is a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate. Co.'s primary product candidate, REN001, is a potent and selective agonist of the peroxisome proliferator-activated receptor delta. Co. is developing REN001 in rare genetic diseases that typically present with myopathy and have high unmet medical needs, including primary mitochondrial myopathies and long-chain fatty acid oxidation disorders.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 125,000 139,755
Total Buy Value $0 $0 $1,000,000 $1,048,692
Total People Bought 0 0 1 2
Total Buy Transactions 0 0 1 7
Total Shares Sold 0 0 115,625 115,625
Total Sell Value $0 $0 $807,798 $807,798
Total People Sold 0 0 2 2
Total Sell Transactions 0 0 2 2
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 49
  Page 1 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Hall Ashley Chief Development Officer   •       –      –    2023-08-28 4 S $6.28 $98,058 D/D (15,625) 39,600 73%     
   Hall Ashley Chief Development Officer   •       –      –    2023-08-28 4 OE $1.80 $28,125 D/D 15,625 55,225     -
   Grey Michael G Executive Chairman   •       •      –    2023-07-26 4 GD $0.00 $0 D/D 50,000 0     -
   Novo A/s 10% Owner   –       –       •   2023-06-23 4 S $7.10 $709,740 D/D (100,000) 3,330,337 -15%     
   Odonnell Niall Director   –       •      –    2023-05-08 4 B $8.00 $1,000,000 I/I 125,000 2,188,713 2.1 -22%     
   Cruse Michael Chief Operating Officer   •       –      –    2022-09-01 4 B $3.39 $25,448 I/I 7,500 13,697 1.99 -26%     
   Grey Michael G Executive Chairman   •       •      –    2022-08-31 4 OE $1.97 $98,500 D/D 50,000 50,000     -
   Cruse Michael Chief Operating Officer   •       –      –    2022-08-31 4 B $3.21 $10,307 I/I 3,212 6,197 1.99 -18%     
   Cruse Michael Chief Operating Officer   •       –      –    2022-08-30 4 B $3.19 $5,893 I/I 1,845 2,985 1.99 -19%     
   Cruse Michael Chief Operating Officer   •       –      –    2022-08-30 4 B $3.16 $3,081 D/D 975 31,758 2.66 -19%     
   Cruse Michael Chief Operating Officer   •       –      –    2022-08-29 4 B $3.24 $3,694 I/I 1,140 1,140 1.91 -18%     
   Cruse Michael Chief Operating Officer   •       –      –    2022-08-29 4 B $3.24 $269 D/D 83 30,783 2.66 -18%     
   Dorenbaum Alejandro Chief Medical Officer   •       –      –    2022-08-12 4 GD $0.00 $0 D/D 22,348 30,000     -
   Lam Jennifer VP of Finance & Administration   •       –      –    2022-03-31 3 IO $0.00 $0 D/D 0 15,000 -12%     
   Cruse Michael Senior VP-Corporate Operations   •       –      –    2021-12-10 4 A $0.00 $0 D/D 25,000 29,100     -
   Flesher Gregory J. President and CEO   •       •      –    2021-12-10 4 A $0.00 $0 D/D 100,000 109,600     -
   Jindal Vineet R. Chief Financial Officer   •       –      –    2021-12-10 4 A $0.00 $0 D/D 30,000 36,600     -
   Dorenbaum Alejandro Chief Medical Officer   •       –      –    2021-12-10 4 A $0.00 $0 D/D 30,000 52,348     -
   Hall Ashley Chief Development Officer   •       –      –    2021-11-12 4 A $0.00 $0 D/D 30,000 30,000     -
   Jindal Vineet R. Chief Financial Officer   •       –      –    2021-08-25 4 B $7.44 $37,177 D/D 5,000 5,000 2.74 29%     
   Cruse Michael Senior VP-Corporate Operations   •       –      –    2021-08-25 4 B $7.45 $18,616 D/D 2,500 2,500 2.74 29%     
   Flesher Gregory J. President and CEO   •       •      –    2021-08-25 4 B $8.00 $64,000 D/D 8,000 8,000 2.81 29%     
   Muralidhar Bali Director   –       •      –    2021-07-14 4 B $8.50 $949,756 I/I 111,736 2,073,957 2.1 -10%     
   Johnson Wendy S. Chief Development Officer   •       –      –    2021-07-14 4 S $8.50 $949,756 D/D (111,736) 0 10%     
   Johnson Wendy S. Chief Development Officer   •       –      –    2021-07-08 4 OE $1.97 $220,120 D/D 111,736 111,736     -

  49 Records found
  1  2   
  Page 1 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed